Discontinuation report JANUMET
| Report ID | 245516 |
| Drug Identification Number | 02333864 |
| Brand name | JANUMET |
| Common or Proper name | sitagliptin and metformin hydrochloride tablets |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 850MG 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 60TAB |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2025-08-30 |
| Actual discontinuation date | |
| Remaining supply date | 2025-08-30 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-12-13 | French | Compare |
| v3 | 2024-12-13 | English | Compare |
| v2 | 2024-12-12 | French | Compare |
| v1 | 2024-12-12 | English | Compare |
Showing 1 to 4 of 4